Jump to main content
Jump to site search


Prospective on using mid-infrared supercontinuum laser sources for in vivo spectral discrimination of disease.

Abstract

Mid-infrared (MIR) fibre-optics may play a future role in in vivo diagnosis of disease, including cancer. Recently, we reported for the first time an optical fibre based broadband supercontinuum (SC) laser source spanning 1.3 to 13.4 μm wavelength to cover the spectral 'fingerprint region' of biological tissue. This work has catalysed the new field of fibre MIR-SC and now very bright sources equivalent to a 'few synchrotrons' have been demonstrated in fibre. In addition, we have made record transparency MIR fibre for routeing the MIR light and reported first-time MIR photoluminescence (with long lifetime) in small-core, rare earth ion doped, MIR fibre - an important step towards MIR fibre lasing at > 4 μm wavelength for pumping fibre MIR-SC. First time fibre MIR-SC spectroscopic imaging of colon tissue is described at wavelengths in the ‘fingerprint region’.

Back to tab navigation

Publication details

The article was received on 24 Jul 2018, accepted on 30 Oct 2018 and first published on 05 Nov 2018


Article type: Minireview
DOI: 10.1039/C8AN01396A
Citation: Analyst, 2018, Accepted Manuscript
  •   Request permissions

    Prospective on using mid-infrared supercontinuum laser sources for in vivo spectral discrimination of disease.

    A. B. Seddon, B. Napier, I. Lindsay, S. Lamrini, P. M. Moselund, N. Stone, O. Bang and M. Farries, Analyst, 2018, Accepted Manuscript , DOI: 10.1039/C8AN01396A

Search articles by author

Spotlight

Advertisements